Literature DB >> 35004956

Liver transplant oncology: is it time to revisit our ideas?

Ramon Soliva1, Joan Figueras1.   

Abstract

Entities:  

Year:  2021        PMID： 35004956      PMCID： PMC8683920          DOI： 10.21037/hbsn-2021-20

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  16 in total

1.  VI consensus document by the Spanish Liver Transplantation Society.

Authors:  Fernando Pardo; José Antonio Pons; Lluís Castells; Jordi Colmenero; Miguel Ángel Gómez; Laura Lladó; Baltasar Pérez; Martín Prieto; Javier Briceño
Journal:  Gastroenterol Hepatol       Date:  2018-06-01       Impact factor: 2.102

2.  Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": Shaking the Coconut Tree.

Authors:  Daniel Azoulay; Chetana Lim
Journal:  Ann Surg       Date:  2020-05       Impact factor: 12.969

3.  Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.

Authors:  Jennifer A Flemming; W Ray Kim; Carol L Brosgart; Norah A Terrault
Journal:  Hepatology       Date:  2016-12-24       Impact factor: 17.425

4.  The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.

Authors:  Kazunari Sasaki; Daisuke Morioka; Simone Conci; Georgios A Margonis; Yu Sawada; Andrea Ruzzenente; Takafumi Kumamoto; Calogero Iacono; Nikolaos Andreatos; Alfredo Guglielmi; Itaru Endo; Timothy M Pawlik
Journal:  Ann Surg       Date:  2018-01       Impact factor: 12.969

5.  A Novel Concept for Partial Liver Transplantation in Nonresectable Colorectal Liver Metastases: The RAPID Concept.

Authors:  Pål-Dag Line; Morten Hagness; Audun Elnaes Berstad; Aksel Foss; Svein Dueland
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

Review 6.  Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents.

Authors:  F Poordad; D Dieterich
Journal:  J Viral Hepat       Date:  2012-07       Impact factor: 3.728

7.  Liver transplantation for nonresectable liver metastases from colorectal cancer.

Authors:  Morten Hagness; Aksel Foss; Pål-Dag Line; Tim Scholz; Pål Foyn Jørgensen; Bjarte Fosby; Kirsten Muri Boberg; Oystein Mathisen; Ivar P Gladhaug; Tor Skatvedt Egge; Steinar Solberg; John Hausken; Svein Dueland
Journal:  Ann Surg       Date:  2013-05       Impact factor: 12.969

8.  Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States.

Authors:  George Cholankeril; Aijaz Ahmed
Journal:  Clin Gastroenterol Hepatol       Date:  2017-12-01       Impact factor: 11.382

9.  Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases.

Authors:  Svein Dueland; Sheraz Yaqub; Trygve Syversveen; Ulrik Carling; Morten Hagness; Kristoffer W Brudvik; Pål-Dag Line
Journal:  JAMA Surg       Date:  2021-06-01       Impact factor: 14.766
View more
  1 in total

1.  Developing a new nomogram to predict early allograft dysfunction after liver transplantation: a nudge in the right direction.

Authors:  Gang Xu; Chen-Hao Jiang; Tao Lv; Jiu-Lin Song; Yong-Jie Zhou; Jian Yang; Li Jiang; Lyu-Nan Yan; Kui Luo; Jia-Yin Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.